Claims for Patent: 5,718,897

Summary for Patent: 5,718,897

Title:	Enhancing keratinocyte migration and proliferation
Abstract:	A method of enhancing the migration and proliferation of keratinocytes in wound healing or in the growth of artificial skin grown in vitro. The wound is contacted with (a) an effective amount of purified Clostridiopeptidase A collagenase that is substantially free from other proteinases and (b) an amount of a growth factor that increases the effects of said collagenase. The artificial skin is grown upon biomatrices previously synthesized by living cells and digested with Clostridiopeptidase A collagenase while in the presence of (a) an effective concentration of purified Clostridiopeptidase A collagenase substantially free from other proteinases and (b) a growth factor in a concentration effective to increase the effectiveness of said collagenase.
Inventor(s):	Herman; Ira M. (Newton, MA)
Assignee:	Trustees of Tufts College (Medford, MA)
Application Number:	08/777,267
Patent Claims:	1. A method of enhancing the migration and proliferation of keratinocytes in human wound healing which comprises contacting same with (a) an effective amount of purified Clostridiopeptidase A collagenase substantially free from other proteinases and (b) an amount of a growth factor that increases the effects of said collagenase. 2. A method according to claim 1 wherein said growth factor is a heparin-binding growth factor. 3. A method according to claim 2 wherein said growth factor is heparin-binding epidermal-like growth factor. 4. A method according to claim 1 wherein said collagenase is applied in the form of an aqueous solution containing from about 0.5 ABC units collagenase/ml to about 150 ABC units/ml. 5. A method according to claim 1 wherein said growth factor is applied in the form of an aqueous solution containing from about 0.01 ng/ml to about 10 ng/ml. 6. A method according to claim 1 wherein said growth factor binds to high-affinity receptors of keratinocytes. 7. A method according to claim 6 wherein said growth factors also binds at low affinity to the sub-cellular matrix. 8. A method of treating an open wound in human skin which comprises contacting the sub-cellular matrix underlying the wound with (a) purified Clostridiopeptidase A collagenase substantially free from other proteinases in a concentration effective to enhance the rate of migration of keratinocytes towards the wound edges and (b) a growth factor that binds to high-affinity receptors of keratinocytes in a concentration effective to increase the effectiveness of said collagenase in stimulating keratinocyte wound healing responses. 9. A method according to claim 8 wherein said growth factor is a heparin-binding growth factor. 10. A method according to claim 9 wherein said growth factor is heparin-binding epidermal-like growth factor. 11. A method according to claim 8 wherein said collagenase is applied in the form of an aqueous solution containing from about 0.5 ABC units collagenase/ml to about 150 ABC units/ml. 12. A method according to claim 8 wherein said growth factor is applied in the form of an aqueous solution containing from about 0.1 ng/ml to about 1.0 ng/ml (i.e. hb EGF). 13. A method of enhancing the migration and proliferation of keratinocytes in mammalian wound healing which comprises contacting same with (a) an effective amount of purified Clostridiopeptidase A collagenase substantially free from other proteinases and (b) an amount of a growth factor that increases the effects of said collagenase. 14. A method according to claim 13 wherein said growth factor binds to high-affinity receptors of keratinocytes. 15. A method according to claim 14 wherein said growth factor also binds at low affinity to the sub-cellular matrix. 16. A method of treating an open wound in mammalian skin which comprises contacting the sub-cellular matrix underlying the wound with (a) purified Clostridiopeptidase A collagenase substantially free from other proteinases in a concentration effective to enhance the rate of migration of keratinocytes towards the wound edges and (b) a growth factor that binds to high affinity receptors of keratinocytes in a concentration effective to increase the effectiveness of said collagenase in stimulating keratinocyte wound healing responses.

Details for Patent 5,718,897

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2015-06-07